Contact Information:

Media Contact

Shana Hutchins

Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości. - Press Release Distribution
RSS - Press News Release
Add Press Release

Texas A&M biologists zero in on 2-protein 2-step trigger for deadly scar-tissue loop

Texas A&M biologists zero in on 2-protein 2-step trigger for deadly scar-tissue loop
( Scientists at Texas A&M University have made additional progress in understanding the process behind scar-tissue formation and wound healing -- specifically, a breakthrough in fibroblast-to-fibrocyte signaling involving two key proteins that work together to promote fibrocyte differentiation to lethal excess -- that could lead to new advances in treating and preventing fibrotic disease.

A new study led by biologists Richard Gomer and Darrell Pilling and involving Texas A&M graduate students Nehemiah Cox and Rice University technician Varsha Vakil points to a naturally occurring blood protein, lumican, that, when stimulated by a fibrocyte-secreted protein called tumor necrosis factor alpha (TNF-alpha), triggers a vicious cycle causing inappropriate and uncontrolled formation of scar tissue in fibrotic diseases. Their work, funded by the National Institutes of Health, is published in the current issue of the Proceedings of the National Academy of Sciences.

Fibrotic diseases occur when the body's natural healing mechanisms malfunction and create excessive scar tissue in vital organs, to the point that it becomes harmful. These diseases are wide-ranging -- lung, kidney, liver and heart fibrosis are some of the most common -- and are associated with 45 percent of U.S. deaths per year.

For their analysis, Gomer and Pilling examined the lung tissue of human patients with pulmonary fibrosis and observed the presence of lumican. In patients with relatively normal lung function, the lumican was present at lower levels, whereas it was more prevalent in patients in advanced stages of the disease.

"Our data suggests that lumican may be one of the unknown signals from fibroblasts to fibrocytes that controls part of a runaway feedback loop that encourages fibrosis," Gomer said. "Therefore, lumican-inhibiting drugs may prove useful as possible therapeutic treatments for fibrosis."

Gomer and Pilling, who joined the Texas A&M Department of Biology in 2010, were able to show in previous studies that bacteria-fighting white blood cells called monocytes enter fibrotic lesions and develop into wound-healing fibrocytes, which are cells that help to mediate tissue repair. Researchers have theorized that the development of fibrosis may involve a miscommunication between fibrocytes and fibroblasts, the main cells that form scar tissue.

In their most recent work, Gomer and Pilling zeroed in on TNF-alpha as a possible source of the miscommunication. While fibroblasts naturally only produce a small amount of lumican, TNF-alpha stimulates them to produce even more lumican during scar formation. The excessive lumican triggers monocytes, which can differentiate to play multiple roles in immune-system function, to become fibrocytes -- a transformation that results in additional TNF-alpha production that, in turn, triggers increased lumican production. Ultimately, this leads to an overabundance of scar tissue in the lungs, a process called a positive feedback loop.

"This research may help explain why fibrosis persists, why it is difficult to treat, and may suggest new methods to treat fibrosis," Pilling said.

Fibrotic diseases and potential treatments have become a hot talking point in biomedical circles in recent years, and both Gomer and Pilling have become nationally recognized as preeminent authorities on fibrotic research.

In the early 2000s, the two identified another naturally occurring blood protein called serum amyloid P, or SAP, as a signal that inhibits the formation of fibrocytes. By 2006, their work to harness SAP's wound healing capabilities had progressed to the point that they co-founded a company, Promedior Inc., to further develop SAP-related technology.

Their first major breakthrough came in 2007, when they and colleagues found that SAP is effective at preventing fibrotic disease in the lungs and hearts of laboratory animals. In 2013 and 2014, Promedior announced that early clinical trials of a treatment involving a recombinant form of SAP, PRM-151, indicated a successful reduction of symptoms in patients with lung fibrosis and myelofibrosis, a life-threatening scarring of bone marrow.

On Aug. 31, New York-based global biopharmaceutical company Bristol-Myers Squibb announced an agreement to give Promedior $150 million to fund further clinical trials and potentially to acquire Promedior for up to $1.25 billion.

"We are obviously delighted that Bristol-Myers Squibb is supporting the work to break the vicious cycle in fibrosis and thus help patients with fibrosing diseases," Gomer said.

From identifying SAP as the protein that inhibits scar-tissue formation to investigating its direct competition, lumican, as the protein that promotes it, Gomer says the real winner in his and Pilling's ongoing research is the patient.

"It looks like SAP rules them all," Gomer said. "The proof of the pudding is that SAP treatments cause patients to improve, not just stabilize. So to our delight, it looks like SAP is a dominant factor."


To learn more about Gomer and Pilling and their research, visit

For additional information about Promedior Inc., go to

[Attachments] See images for this press release:
Texas A&M biologists zero in on 2-protein 2-step trigger for deadly scar-tissue loop Texas A&M biologists zero in on 2-protein 2-step trigger for deadly scar-tissue loop 2 Texas A&M biologists zero in on 2-protein 2-step trigger for deadly scar-tissue loop 3


Bats and balls, not base runners, cause worst injuries to major league catchers

Contrary to popular belief, the worst injuries baseball catchers face on the field come from errant bats and foul balls, not home-plate collisions with base runners, according to findings of a study led by researchers at the Johns Hopkins University School of Medicine. The research, done in collaboration with Baltimore Orioles trainers Brian Ebel and Richard Bancells, involved analysis of all catcher injuries during major league baseball games over a 10-year period. A summary of the findings, published ahead of print Aug. 28 in the American Journal of Sports Medicine, ...

Hypertension in professional football players likely results from trauma on the field

Hypertension in professional football players likely results from trauma on the field
AUGUSTA, Ga. - The regular physical trauma that appears to put professional football players at risk for degenerative brain disease may also increase their risk for hypertension and cardiovascular disease, researchers say. The frequent hits football players experience, particularly frontline defenders such as linemen, likely continually activate the body's natural defense system, producing chronic inflammation that is known to drive blood pressure up, according to a study in The FASEB Journal. While strenuous physical activity clearly has its benefits, it also produces ...

New drug-like compounds may improve odds of men battling prostate cancer, researchers find

New drug-like compounds may improve odds of men battling prostate cancer, researchers find
Researchers at Southern Methodist University, Dallas, have discovered three new drug-like compounds that could ultimately offer better odds of survival to prostate cancer patients. The drug-like compounds can be modified and developed into medicines that target a protein in the human body that is responsible for chemotherapy resistance in cancers, said biochemist Pia D. Vogel, lead author on the scientific paper reporting the discovery. So far there's no approved drug on the market that reverses cancer chemotherapy resistance caused by P-glycoprotein, or P-gp for short, ...

Stem cell-derived 'mini-brains' reveal potential drug treatment for rare disorder

Using "mini-brains" built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to "rescue" dysfunctional cells by suppressing a critical genetic alteration. Their findings are published in the September 8 online issue of Molecular Psychiatry. The neurological disorder is called MECP2 duplication syndrome. First described in 2005, it is caused by duplication of genetic material in a specific ...

Physicians highlight ENT research to be presented during otolaryngology's annual meeting

ALEXANDRIA, VA--The latest research on hearing loss, head and neck cancers, sleep apnea and other otolaryngic topics will be presented in Dallas, TX, September 27-30, at the 2015 Annual Meeting & OTO EXPO? of the American Academy of Otolaryngology--Head and Neck Surgery Foundation (AAO-HNSF), the largest annual meeting of ear, nose, throat, head and neck physicians in the world. Abstracts of the research to be presented are now available online at The 2015 Annual Meeting features more than 380 oral and 180 poster presentations ...

New guidelines address long-term needs of colorectal cancer survivors

ATLANTA - September 8, 2015-New American Cancer Society Cancer Survivorship Care guidelines released today provide primary care clinicians with recommendations for providing comprehensive care to the estimated 1.2 million survivors of colorectal cancer in the United States. The guidelines are the second to be published in a series of cancer survivorship care guidelines developed by the American Cancer Society. They provide guidance on identifying and managing potential physical and psychosocial long-term and late effects of colorectal cancer and its treatment, as well ...

E-cigarettes serve as gateway to smoking for teens and young adults

PITTSBURGH, Sept. 8, 2015 - Young people across the United States who smoke electronic cigarettes are considerably more likely to start smoking traditional cigarettes within a year than their peers who do not smoke e-cigarettes, according to an analysis led by the University of Pittsburgh Center for Research on Media, Technology, and Health (CRMTH) and the Dartmouth-Hitchcock Norris Cotton Cancer Center. The study, funded by the National Cancer Institute (NCI), was the first to assess this relation in a national U.S. sample of youth, and to include people older than 18 ...

Continued smoking after MS diagnosis associated with accelerated disease progression

Continued smoking after a diagnosis of multiple sclerosis (MS) appears to be associated with accelerated disease progression compared with those patients who quit smoking, according to an article published online by JAMA Neurology. MS is a neurogenerative disease and smoking is one of its known risk factors. While MS begins with an initial course of irregular and worsening relapses, it usually changes after about 20 years into secondary progressive (SP) disease. The time from onset to conversion to SPMS is a frequently used measure of disease progression. Jan Hillert, ...

Survivors of child trafficking exhibit symptoms of depression, anxiety, PTSD

About one-third of girls and boys who survived child trafficking experienced physical and/or sexual violence during their ordeal in a study of children receiving posttrafficking services in Cambodia, Thailand and Vietnam, according to an article published online by JAMA Pediatrics. Many of these survivors of child trafficking in the Greater Mekong Subregion of Southeast Asia screened positive for depression, anxiety and posttraumatic stress disorder (PTSD), and mental health symptoms were associated with self-harm and suicide ideation, according to the article. Millions ...

Progression to traditional cigarettes after electronic cigarette use in young people

A new study of U.S. adolescents and young people suggests that using electronic cigarettes was associated with progression to traditional cigarette smoking, according to an article published online by JAMA Pediatrics. Some studies suggest e-cigarettes may help smokers reduce the use of traditional tobacco products. Still, there is concern that e-cigarette marketing could position the product to recruit nonsmokers and the use of e-cigarettes has increased among both adolescents and young adults. Brian A. Primack, M.D., Ph.D., of the University of Pittsburgh School of ...


How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[] Texas A&M biologists zero in on 2-protein 2-step trigger for deadly scar-tissue loop is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.